LIN7C
Protein lin-7 homolog C
Also known as: FLJ11215, LIN-7-C, LIN-7C, LIN7C_HUMAN, MALS-3, VELI3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NUP9
- Gene
- LIN7C
- Ensembl
- ENSG00000148943
- Chromosome
- 11
- Canonical length
- 197 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables L27 domain binding activity and cytoskeletal protein binding activity. Involved in morphogenesis of an epithelial sheet. Located in cell-cell junction; cytoplasm; and plasma membrane. Part of MPP7-DLG1-LIN7 complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
197 residues, UniProt reviewed canonical sequence.
>Q9NUP9|LIN7C
1 MAALGEPVRL ERDICRAIEL LEKLQRSGEV PPQKLQALQR VLQSEFCNAV REVYEHVYET
61 VDISSSPEVR ANATAKATVA AFAASEGHSH PRVVELPKTE EGLGFNIMGG KEQNSPIYIS
121 RIIPGGIADR HGGLKRGDQL LSVNGVSVEG EHHEKAVELL KAAQGKVKLV VRYTPKVLEE
181 MESRFEKMRS AKRRQQTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LIN7C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- liver: 23 nTPM
- cerebellum: 21 nTPM
- bone marrow: 15 nTPM
- thyroid gland: 13 nTPM
- kidney: 11 nTPM
- skin: 11 nTPM
Single-cell type
- parietal cells: 80 nCPM
- hepatocytes: 78 nCPM
- gastric chief cells: 71 nCPM
- mucous neck cells: 60 nCPM
- suprabasal keratinocytes: 59 nCPM
- esophageal suprabasal cells: 58 nCPM
Immune cell
- basophil: 17 nTPM
- non-classical monocyte: 10 nTPM
- eosinophil: 9.6 nTPM
- naive CD4 T-cell: 9.4 nTPM
- MAIT T-cell: 9 nTPM
- intermediate monocyte: 8.5 nTPM
Brain region
- cerebellum: 74 nTPM
- hypothalamus: 36 nTPM
- midbrain: 35 nTPM
- cerebral cortex: 33 nTPM
- hippocampal formation: 33 nTPM
- spinal cord: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 1.09
- DepMap mean gene effect
- -0.24
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- exocytosis
- morphogenesis of an epithelial sheet
- neurotransmitter secretion
- protein transport
- regulation of synaptic assembly at neuromuscular junction
- synaptic vesicle transport
Molecular functions
- cytoskeletal protein binding
- L27 domain binding
- PDZ domain binding
- protein domain specific binding
- protein-macromolecule adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LIN7C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LIN7C as an antibody target. Whether an autoantibody or antibody against LIN7C could matter depends on whether native LIN7C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LIN7C is annotated at the cell surface, where native LIN7C is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LIN7C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...